An abstract to be presented by the American Academy of Neurology (CA, USA) reports patients suffering from hand tremors may find relief with a novel, non-invasive nerve stimulation treatment.
A recently published study has indicated that all degrees of concussion may increase the risk of developing Parkinson’s disease.
A preliminary study has revealed that an investigational drug may help increase protein levels in babies with spinal muscular atrophy.
A preliminary study has revealed that a monoclonal antibody could prevent difficult-to-treat migraines in patients who have tried unsuccessfully to prevent them using other treatments.
A new study has revealed that a nasal spray formulation of ketamine demonstrates promise in the rapid treatment of symptoms of major depression and suicidal thoughts.
In this week’s industry news round-up we set the focus on Alzheimer’s disease (AD), with another clinical trial termination announced and a new framework for defining AD.
We bring together Parkinson’s advances from across research and industry from the year so far.
In one of the largest studies of its kind, researchers reveal that the number of traumatic brain injuries and severity could heighten the risk of dementia.
A research team has identified a gene that, upon elimination, could potentially spur regeneration of axons in nerve cells severed by spinal cord injury.
New research has suggested that a protein involved in Alzheimer’s disease may also be implicated in HIV-associated neurological disorders, suggesting Alzheimer’s therapies may benefit a subset of HIV patients.